You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

163 Results
Guidelines and Advice
Guidelines and Advice
Guidelines and Advice
Guidelines and Advice
Status: Current
ID: GL-C50-20
May 2015
Drug
Other Name(s): Vepesid®
Jul 2020
Drug
Jul 2020
Drug
Other Name(s): Provera® (multiple brands available)
Apr 2015
Drug
Other Name(s): Zinecard®
Dec 2020
Drug
Other Name(s): Procytox®
Oct 2020
Regimen
Cancer Type:
Gynecologic, 
Gestational Trophoblastic Disease
Intent: Curative
Jun 2020
Regimen
Intent: Adjuvant
Funding:
ODB - General Benefit
    exemestane
Nov 2020

Pages